Entrada Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $45M | 3.0M | 15.09 |
| 2023-09-30 | $47M | 3.0M | 15.80 |
| 2023-06-30 | $45M | 2.9M | 15.14 |
| 2023-03-31 | $43M | 3.0M | 14.50 |
| 2022-12-31 | $41M | 3.0M | 13.52 |
| 2022-03-31 | $23M | 2.5M | 9.39 |
| 2021-12-31 | $35M | 2.0M | 17.12 |